28
Nov

Lachman Consultants to Participate in Scrip Awards

For the past 18 years, the Scrip Awards has been taking place in London where over 400 industry leaders gather to celebrate and recognize the best innovations and achievements in the global biopharmaceutical industry. This year, Lachman CEO and President Frances Zipp and John Darby, Senior Director will be attending to celebrate the winners across […]

Read More
25
Oct

Marty Shimer to Speak at AAM’s GRx+Biosims Meeting

On Tuesday, November 8, 2022, as part of the GRx+Biosims conference being held by the Association for Accessible Medicines, Marty Shimer will be participating on a panel in the Science and Regulatory Learning Track on pH Adjusters and Q1/Q2 Assessments. This session will explore FDA’s plans for pH adjusters and Q1/Q2 assessments and provide industry […]

Read More
11
Jul

Lachman Consultant Services, Inc. Names Marty Shimer as Executive Director, Regulatory

(Westbury, NY – July 11, 2022) – Frances Zipp, President and CEO of Lachman Consultant Services, Inc. (Lachman Consultants), a leading provider of compliance, regulatory affairs, and technical services to global life sciences organizations, announced today that CAPT Martin H. Shimer, II joined the firm as Executive Director, Regulatory, effective July 11, 2022. In this […]

Read More
14
Jun

Fran Zipp to Present at Medicines for Europe

On Thursday, June 30th, at the Annual Conference of Medicines for Europe, Frances Zipp, President and CEO of Lachman Consultant Services, Inc., will be addressing the audience as a part of the Keynote Speech at the Dolce Sitges Hotel in Barcelona, Spain.  Fran will be addressing humanitarian efforts by industry to provide patients in war-torn […]

Read More
17
Mar
Lachman New Hire Image

Lachman Consultants, Inc. Names John McShane, M.B.A., as VP of Cell & Gene Therapy, Compliance and Business Development

(Westbury, NY – March 16, 2021) Fran Zipp, President and CEO of Lachman Consultants, Inc., a leading provider of compliance, regulatory affairs, and technical services to global life sciences organizations, today announced that John McShane has joined the firm as Vice President of Cell & Gene Therapy, Compliance and Business Development. In this role, McShane […]

Read More
04
Dec

Fran Zipp, CEO and President of Lachman Consultants, to Present Opening Address at ISPE Singapore on December 9

On Wednesday, December 9, 2020, Fran Zipp, CEO and President of Lachman Consultants will be delivering the Opening Address during the Joint Opening Plenary Sessions of the ISPE Singapore Affiliate Virtual Conference. Joining her in the Joint Opening Plenary are Pierre Winnepenninckx, Conference Chair, ISPE Singapore Affiliate, and Shanshan Liu, President, ISPE Singapore Affiliate, as well as regulators […]

Read More
18
Nov

Lachman Consultants Named “Top-Ten Medical Device Consulting Company” by Med-Tech Outlook

(Westbury, NY— November 2020) Lachman Consultant Services, Inc. (Lachman Consultants), a provider of compliance, regulatory, and technical consulting services to the global pharmaceutical and related industries, was recently named a “Top-Ten Medical Device Consulting Company” by highly-regarded, industry publication MedTech Outlook. In making the announcement in its September issue, the monthly periodical outlined that its […]

Read More
10
Nov

Fran Zipp, Lachman Consultants’ CEO to Deliver Opening Address at 2020 ISPE Singapore Virtual Conference

(Westbury, NY— November 2020) Fran Zipp, Past International Board Chair, ISPE and CEO of Lachman Consultants is scheduled to deliver opening remarks at the 2020 ISPE Singapore Affiliate Conference & Exhibition. The three-day virtual event featuring programs, seminars, leading-edge technology, and presentations by top industry experts will take place Wednesday, December 9th through Friday, December […]

Read More
09
Nov

Scott Deckebach to Participate in Virtual Panel Discussion on the “New Normal” for Quality Practices During Pandemic

On November 11, 2020, Lachman’s Scott Deckebach MBA, Director, Compliance, Lachman Consultants will be participating in a panel discussion during the 2020 Bio/Pharma Virtual Congress, “‘New Normal’ for Quality Practices”. This discussion will review quality and regulatory challenges amid the pandemic, focusing on new technologies such as remote monitoring, risk-based quality management, Annex 1 changes […]

Read More
1 2 11